MedTrace Logo

Effects of Anesthesia on Immunity in Cancer

NCT03514550 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-06-03

No results posted yet for this study

Summary

The aim of the study is a comparative study of the cellular immunity response of patients operated on for kidney cancer under total intravenous and inhalational anesthesia.

Conditions

  • Surgery
  • Renal Cancer

Interventions

DRUG

Propofol

Propofol will be used for anesthesia during surgery

DRUG

Sevoflurane

Sevoflurane will be used for anesthesia during surgery

PROCEDURE

Epidural block

Epidural catheterization Th9-Th10, ropivacaine for perioperative analgesia

Sponsors & Collaborators

  • Meshalkin Research Institute of Pathology of Circulation

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-14
Primary Completion
2019-04-01
Completion
2019-05-20

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03514550 on ClinicalTrials.gov